Detalhe da pesquisa
1.
Longitudinal study of inflammation and relapse in schizophrenia.
Schizophr Res
; 252: 88-95, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36634452
2.
Association between type-three metabotropic glutamate receptor gene (GRM3) variants and symptom presentation in treatment refractory schizophrenia.
Hum Psychopharmacol
; 26(1): 28-34, 2011 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-21344500
3.
A candidate gene study of Tardive dyskinesia in the CATIE schizophrenia trial.
Am J Med Genet B Neuropsychiatr Genet
; 153B(1): 336-40, 2010 Jan 05.
Artigo
Inglês
| MEDLINE | ID: mdl-19475583
4.
Extrapyramidal side-effects of antipsychotics in a randomised trial.
Br J Psychiatry
; 193(4): 279-88, 2008 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-18827289
5.
Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C/T and 1298A/C variants.
Schizophr Res
; 98(1-3): 47-54, 2008 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-17976958
6.
The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: results from the CATIE study.
Schizophr Res
; 100(1-3): 39-52, 2008 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-18191383
7.
Sex, race, and smoking impact olanzapine exposure.
J Clin Pharmacol
; 48(2): 157-65, 2008 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-18199892
8.
Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder.
Ann Clin Psychiatry
; 20(3): 131-7, 2008.
Artigo
Inglês
| MEDLINE | ID: mdl-18633739
9.
Predicting relapse in schizophrenia: Is BDNF a plausible biological marker?
Schizophr Res
; 193: 263-268, 2018 03.
Artigo
Inglês
| MEDLINE | ID: mdl-28734907
10.
Baseline neurocognitive deficits in the CATIE schizophrenia trial.
Neuropsychopharmacology
; 31(9): 2033-46, 2006 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-16641947
11.
Baseline use of concomitant psychotropic medications to treat schizophrenia in the CATIE trial.
Psychiatr Serv
; 57(8): 1094-101, 2006 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-16870959
12.
Substance use and psychosocial functioning in schizophrenia among new enrollees in the NIMH CATIE study.
Psychiatr Serv
; 57(8): 1110-6, 2006 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-16870961
13.
Comparison of Injectable and Oral Antipsychotics in Relapse Rates in a Pragmatic 30-Month Schizophrenia Relapse Prevention Study.
Psychiatr Serv
; 67(12): 1370-1372, 2016 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27476806
14.
Clinicians' recognition of the metabolic adverse effects of antipsychotic medications.
Schizophr Res
; 79(2-3): 281-8, 2005 Nov 15.
Artigo
Inglês
| MEDLINE | ID: mdl-15964743
15.
Clinical correlates of tardive dyskinesia in schizophrenia: baseline data from the CATIE schizophrenia trial.
Schizophr Res
; 80(1): 33-43, 2005 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-16171976
16.
Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study.
Schizophr Bull
; 41(2): 449-59, 2015 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-24870446
17.
The effects of neuroleptic medications on basal ganglia blood flow in schizophreniform disorders: a comparison between the neuroleptic-naïve and medicated states.
Biol Psychiatry
; 52(9): 855-62, 2002 Nov 01.
Artigo
Inglês
| MEDLINE | ID: mdl-12399138
18.
The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update.
J Clin Psychiatry
; 65(4): 500-8, 2004 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-15119912
19.
Atypical antipsychotics: sleep, sedation, and efficacy.
Prim Care Companion J Clin Psychiatry
; 6(Suppl 2): 3-7, 2004.
Artigo
Inglês
| MEDLINE | ID: mdl-16001094
20.
Evidence for accelerated vascular aging in bipolar disorder.
J Psychosom Res
; 73(3): 175-9, 2012 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-22850256